Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study
Clinical trial NCT03464201 · COMPLETED
Trial details
- NCT number
- NCT03464201
- Sponsor
- Grupo Español de Tumores Huérfanos e Infrecuentes
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-13
- Primary completion
- 2020-11-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.